Possible Neurophysiological Markers of Early Neurodegenerative Process: Parkinson’s Disease

被引：0

作者：

B. Kh. Baziyan

机构：

[1] Russian Academy of Medical Sciences,Laboratory of Neurocybernetics, Research Center of Neurology

来源：

Bulletin of Experimental Biology and Medicine | 2012年 / 154卷

关键词：

Parkinson’s disease; eye, head, and hand movements; coordination; neurophysiological markers; neurodegenerative processes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

We used tests for evaluation of latent period, duration, and accuracy of eyes, head, or hand movements and their coordinated movements. Comparative analysis of these parameters was performed in healthy subjects and in patients with early stages of Parkinson’s disease. The pathology data significantly (p<0.05) differed from those in normal control subjects. These results can be used as neurophysiological markers of early neurodegenerative process. Increasing the number of tests would lead to better specificity of the markers. It will be possible to create a battery of neurophysiological tests most likely reflecting the predictive basis of early neurodegenerative process.

引用

页码：186 / 188

页数：2

共 50 条

[31] Neurodegenerative disease: New leads for Parkinson's disease
Kingwell K.
Nature Reviews Neuroscience, 2010, 11 (10) : 666 - 667
[32] Parkinson's disease -: a multifactorial neurodegenerative disorder
Riess, O
Krüger, R
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 113 - 125
[33] Neurodegenerative disease: Pieces of the Parkinson's puzzle
Ozawa Y.
Nature Reviews Neuroscience, 2010, 11 (12) : 787 - 787
[34] PARKINSON DISEASE - TO BE DIAGNOSED AS EARLY AS POSSIBLE
HENRY, R
UNION MEDICALE DU CANADA, 1991, 120 (02): : 91 - &
[35] CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
Ju-Hee Kang
Brit Mollenhauer
Christopher S. Coffey
Jon B. Toledo
Daniel Weintraub
Douglas R. Galasko
David J. Irwin
Vivianna Van Deerlin
Alice S. Chen-Plotkin
Chelsea Caspell-Garcia
Teresa Waligórska
Peggy Taylor
Nirali Shah
Sarah Pan
Pawel Zero
Mark Frasier
Kenneth Marek
Karl Kieburtz
Danna Jennings
Caroline M. Tanner
Tanya Simuni
Andrew Singleton
Arthur W. Toga
Sohini Chowdhury
John Q. Trojanowski
Leslie M. Shaw
Acta Neuropathologica, 2016, 131 : 935 - 949
[36] Challenges of Teleneurology in the Care of Complex Neurodegenerative Disorders: The Case of Parkinson's Disease with Possible Solutions
Fereshtehnejad, Seyed-Mohammad
Lokk, Johan
HEALTHCARE, 2023, 11 (24)
[37] CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study
Kang, Ju-Hee
Mollenhauer, Brit
Coffey, Christopher S.
Toledo, Jon B.
Weintraub, Daniel
Galasko, Douglas R.
Irwin, David J.
Van Deerlin, Vivianna
Chen-Plotkin, Alice S.
Caspell-Garcia, Chelsea
Waligorska, Teresa
Taylor, Peggy
Shah, Nirali
Pan, Sarah
Zero, Pawel
Frasier, Mark
Marek, Kenneth
Kieburtz, Karl
Jennings, Danna
Tanner, Caroline M.
Simuni, Tanya
Singleton, Andrew
Toga, Arthur W.
Chowdhury, Sohini
Trojanowski, John Q.
Shaw, Leslie M.
ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 935 - 949
[38] Depressive illness in Parkinson's disease -: indication of a more advanced and widespread neurodegenerative process?
Palhagen, S. E.
Carlsson, M.
Curman, E.
Walinder, J.
Granerus, A. -K.
ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (05): : 295 - 304
[39] Early risk markers of Parkinson's disease in patients with malignant melanoma
Voss, J.
Heilmann, E.
Trcka, J.
Gross, G. E.
Benecke, R.
Walter, U.
MOVEMENT DISORDERS, 2014, 29 : S394 - S395
[40] Cerebrospinal fluid protein markers of cognition in early Parkinson's disease
Markaki, I.
Bergstrom, S.
Tsitsi, P.
Remnestal, J.
Manberg, A.
Hertz, E.
Paslawski, W.
Uhlen, M.
Mangone, G.
Carvalho, S.
Rascol, O.
Meissner, W.
Magnin, E.
Wullner, U.
Corvol, J. C.
Nilsson, P.
Svenningsson, P.
MOVEMENT DISORDERS, 2020, 35 : S178 - S178

← 1 2 3 4 5 →